CHR | SNP | Position | Locus | Allele 1 | Allele 2 | Effect | Standard error | p Value | OR (95% CI) | TASC OR (95% CI) | TASC p value |
---|---|---|---|---|---|---|---|---|---|---|---|
12 | rs4149577 | 6317783 | TNFRSF1A | T | C | −0.23 | 0.069 | 8.2×10−4 | 0.79 (0.69 to 0.91) | 0.9 (0.79 to 1.01) | 0.052 |
17 | rs2293152 | 37735055 | STAT3 | C | G | −0.21 | 0.065 | 0.0015 | 0.81 (0.72 to 0.92) | 0.88 (0.81 to 0.96) | 0.0016 |
5 | rs27038 | 96138710 | ERAP1 | A | G | 0.17 | 0.065 | 0.0091 | 1.18 (1.04 to 1.34) | 1.26 (1.17 to 1.35) | 2.2×10−7 |
5 | rs27037 | 96120450 | ERAP1 | T | G | 0.17 | 0.066 | 0.0092 | 1.19 (1.04 to 1.35) | 1.28 (1.17 to 1.39) | 1.2×10−5 |
17 | rs1053005 | 37719436 | STAT3 | G | A | 0.16 | 0.069 | 0.017 | 1.18 (1.03 to 1.35) | 0.95 (0.85 to 1.05) | 0.32 |
5 | rs27980 | 96123651 | ERAP1 | C | A | −0.15 | 0.064 | 0.022 | 0.86 (0.76 to 0.98) | 0.97 (0.89 to 1.06) | 0.52 |
2 | rs10865331 | 62404976 | 2p15 | A | G | 0.15 | 0.065 | 0.023 | 1.16 (1.02 to 1.32) | 1.35 (1.27 to 1.42) | 1.9×10−14 |
5 | rs27619 | 96143821 | ERAP1 | C | A | −0.13 | 0.065 | 0.038 | 0.87 (0.77 to 0.99) | 0.8 (0.72 to 0.88) | 8.9×10−8 |
5 | rs469783 | 96147280 | ERAP1 | T | C | −0.13 | 0.065 | 0.039 | 0.88 (0.77 to 0.99) | 0.77 (0.67 to 0.86) | 1.1×10−7 |
5 | rs7711564 | 96121975 | ERAP1 | G | C | −0.13 | 0.065 | 0.045 | 0.88 (0.77 to 1) | 1 (0.92 to 1.08) | 0.96 |
6 | rs7740197 | 26771457 | 6p22.1 | G | A | −0.20 | 0.10 | 0.049 | 0.82 (0.67 to 1) | 1.3 (1.19 to 1.41) | 4.1×10−6 |
CHR, chromosome; SNP, single nucleotide polymorphism; TASC, Australo-Anglo-American Spondyloarthritis Consortium.